CARDIOFOCUS, INC.

Profile

Company Names

CARDIOFOCUS, INC.

Addresses

500 NICKERSON ROAD, SUITE 500-200, MARLBOROUGH, MA 01752

Phone Numbers

508-658-7237

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$153,218,525.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2023-02-08 
$27,155,857.00 
$31,755,859.00 
$4,600,002.00 
Equity, Debt 
12
2022-03-30 
$3,999,998.00 
$49,999,998.00 
$46,000,000.00 
Equity 
11
2020-07-07 
$12,020,000.00 
$15,000,000.00 
$2,980,000.00 
Equity 
10
2019-05-09 
$8,000,000.00 
$12,000,000.00 
$4,000,000.00 
Equity 
9
2018-04-04 
$13,000,000.00 
$21,000,000.00 
$8,000,000.00 
Debt 
8
2017-02-15 
$20,178,554.00 
$32,060,261.00 
$11,881,707.00 
Equity 
7
2016-05-11 
$8,000,000.00 
$12,000,000.00 
$4,000,000.00 
Equity, Debt 
6
2014-12-22 
$31,652,646.00 
$33,200,654.00 
$1,548,008.00 
Equity 
5
2014-11-07 
$2,300,000.00 
$2,300,000.00 
$0.00 
Equity, Debt 
4
2014-04-29 
$2,378,923.00 
$5,000,000.00 
$2,621,077.00 
Equity, Debt 
3
2011-02-10 
$13,639,082.00 
$15,639,082.00 
$2,000,000.00 
Equity 
2
2010-04-08 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity, Debt 
1
2009-06-15 
$5,893,465.00 
$9,200,000.00 
$3,306,535.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
OMAR 
 
ANIRANA 
DIRECTOR
BURKE 
 
BARRETT 
EXECUTIVE OFFICER, DIRECTOR
OMARI 
 
BOUKNIGHT 
EXECUTIVE OFFICER
WARREN 
 
CLARK 
EXECUTIVE OFFICER
WARREN 
CLARK III 
EXECUTIVE OFFICER
WARREN 
R. 
CLARK III 
EXECUTIVE OFFICER
WARREN 
 
CLARK, III 
EXECUTIVE OFFICER
WARREN 
R. 
CLARK, III 
EXECUTIVE OFFICER
SCOTT 
 
FLETCHER 
EXECUTIVE OFFICER
LAUREN 
 
JENNINGS 
EXECUTIVE OFFICER
DAVID 
 
KHO 
DIRECTOR
MARLENE 
 
KRAUSS 
DIRECTOR
DAVID 
R. 
KRESSLER 
EXECUTIVE OFFICER
CHRISTOPHER 
 
KROEGER 
DIRECTOR
CHRISTOPHER 
KROEGER 
DIRECTOR
CHRISTOPHER 
A. 
KROEGER 
DIRECTOR
CHARLES 
 
LARSEN 
DIRECTOR
CHARLES 
LARSEN 
DIRECTOR
CHARLES 
E. 
LARSEN 
DIRECTOR
CHARLES 
 
LARSON 
DIRECTOR
STEPHAN 
 
OGILVIE 
EXECUTIVE OFFICER
BRUCE 
ROBERTSON 
DIRECTOR
BRUCE 
C. 
ROBERTSON 
DIRECTOR
ANJIE 
 
ROLDAN 
EXECUTIVE OFFICER
STEPHEN 
 
SAGON 
EXECUTIVE OFFICER, DIRECTOR
STEPHEN 
SAGON 
EXECUTIVE OFFICER, DIRECTOR
STEPHEN 
W. 
SAGON 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
SCHULTE 
DIRECTOR
GWEN 
 
WATANABE 
DIRECTOR
PATRICK 
 
WETHINGTON 
DIRECTOR
PATRICK 
J. 
WETHINGTON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-02-08 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-30 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-05-11 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-04-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TRUMP SECURITIES LLC